A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia | Zendy

AI Assistant Blog Pricing

A double-blind, placebo-controlled, randomized withdrawal study of lurasidone for the maintenance of efficacy in patients with schizophrenia

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.